Market Closed -
Japan Exchange
02:00:00 2024-05-21 am EDT
|
5-day change
|
1st Jan Change
|
2,805
JPY
|
-2.65%
|
|
-6.34%
|
-1.34%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
323,906
|
337,648
|
336,849
|
421,488
|
631,946
|
657,382
|
-
|
-
|
Enterprise Value (EV)
1 |
291,219
|
299,636
|
291,984
|
370,080
|
563,688
|
676,888
|
574,449
|
545,037
|
P/E ratio
|
33
x
|
21.9
x
|
20.1
x
|
20.1
x
|
24
x
|
21.9
x
|
19.2
x
|
17
x
|
Yield
|
0.88%
|
0.88%
|
0.95%
|
0.97%
|
0.79%
|
0.91%
|
1.05%
|
1.12%
|
Capitalization / Revenue
|
1.76
x
|
1.79
x
|
1.86
x
|
2.11
x
|
2.65
x
|
2.5
x
|
2.2
x
|
2.06
x
|
EV / Revenue
|
1.59
x
|
1.59
x
|
1.61
x
|
1.85
x
|
2.36
x
|
2.5
x
|
1.92
x
|
1.7
x
|
EV / EBITDA
|
10.7
x
|
9.98
x
|
9.82
x
|
10
x
|
13.5
x
|
13.9
x
|
10.6
x
|
9.07
x
|
EV / FCF
|
19.3
x
|
25
x
|
30.5
x
|
34.1
x
|
31.8
x
|
28
x
|
19.8
x
|
16.2
x
|
FCF Yield
|
5.19%
|
4%
|
3.28%
|
2.93%
|
3.15%
|
3.57%
|
5.05%
|
6.15%
|
Price to Book
|
2.48
x
|
2.43
x
|
2.17
x
|
2.37
x
|
3.02
x
|
2.75
x
|
2.59
x
|
2.28
x
|
Nbr of stocks (in thousands)
|
227,942
|
228,140
|
228,140
|
228,140
|
228,139
|
228,139
|
-
|
-
|
Reference price
2 |
1,421
|
1,480
|
1,476
|
1,848
|
2,770
|
2,882
|
2,882
|
2,882
|
Announcement Date
|
5/10/19
|
5/12/20
|
5/12/21
|
5/12/22
|
5/12/23
|
5/13/24
|
-
|
-
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
183,582
|
188,327
|
181,287
|
199,646
|
238,664
|
270,840
|
298,459
|
319,862
|
EBITDA
1 |
27,216
|
30,022
|
29,738
|
37,022
|
41,760
|
48,735
|
54,415
|
60,070
|
EBIT
1 |
20,812
|
23,085
|
22,990
|
29,349
|
33,959
|
40,048
|
45,171
|
51,075
|
Operating Margin
|
11.34%
|
12.26%
|
12.68%
|
14.7%
|
14.23%
|
14.79%
|
15.13%
|
15.97%
|
Earnings before Tax (EBT)
1 |
16,300
|
21,730
|
23,006
|
27,953
|
34,290
|
41,518
|
47,392
|
53,433
|
Net income
1 |
9,799
|
15,410
|
16,743
|
21,018
|
26,377
|
30,936
|
34,207
|
38,684
|
Net margin
|
5.34%
|
8.18%
|
9.24%
|
10.53%
|
11.05%
|
11.42%
|
11.46%
|
12.09%
|
EPS
2 |
43.00
|
67.56
|
73.39
|
92.13
|
115.6
|
135.6
|
149.9
|
169.6
|
Free Cash Flow
1 |
15,128
|
11,971
|
9,574
|
10,844
|
17,748
|
24,145
|
29,017
|
33,546
|
FCF margin
|
8.24%
|
6.36%
|
5.28%
|
5.43%
|
7.44%
|
8.91%
|
9.72%
|
10.49%
|
FCF Conversion (EBITDA)
|
55.58%
|
39.87%
|
32.19%
|
29.29%
|
42.5%
|
49.54%
|
53.33%
|
55.84%
|
FCF Conversion (Net income)
|
154.38%
|
77.68%
|
57.18%
|
51.59%
|
67.29%
|
78.05%
|
84.83%
|
86.72%
|
Dividend per Share
2 |
12.50
|
13.00
|
14.00
|
18.00
|
22.00
|
27.00
|
30.25
|
32.29
|
Announcement Date
|
5/10/19
|
5/12/20
|
5/12/21
|
5/12/22
|
5/12/23
|
5/13/24
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 Q2
|
2025 S1
|
2025 Q3
|
2025 Q4
|
2025 S2
|
---|
Net sales
1 |
90,428
|
97,899
|
83,004
|
98,283
|
48,704
|
91,019
|
53,003
|
55,624
|
108,627
|
52,255
|
58,058
|
110,313
|
65,950
|
62,401
|
61,171
|
66,698
|
127,869
|
73,294
|
69,677
|
142,971
|
67,450
|
73,250
|
140,100
|
80,700
|
77,600
|
154,400
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
10,393
|
12,692
|
10,779
|
12,211
|
7,763
|
13,771
|
9,777
|
5,801
|
15,578
|
8,302
|
7,967
|
16,269
|
12,329
|
5,361
|
11,292
|
9,674
|
20,966
|
14,296
|
4,786
|
19,082
|
11,950
|
11,200
|
23,800
|
15,900
|
7,650
|
23,700
|
Operating Margin
|
11.49%
|
12.96%
|
12.99%
|
12.42%
|
15.94%
|
15.13%
|
18.45%
|
10.43%
|
14.34%
|
15.89%
|
13.72%
|
14.75%
|
18.69%
|
8.59%
|
18.46%
|
14.5%
|
16.4%
|
19.51%
|
6.87%
|
13.35%
|
17.72%
|
15.29%
|
16.99%
|
19.7%
|
9.86%
|
15.35%
|
Earnings before Tax (EBT)
|
10,478
|
11,252
|
9,050
|
13,956
|
7,429
|
13,840
|
9,709
|
4,404
|
-
|
9,655
|
8,155
|
17,810
|
11,717
|
4,763
|
12,242
|
10,302
|
22,544
|
14,026
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
7,305
|
8,105
|
6,178
|
10,565
|
6,025
|
10,756
|
6,177
|
4,085
|
10,262
|
6,994
|
6,198
|
13,192
|
8,445
|
4,740
|
9,090
|
7,504
|
16,594
|
9,563
|
4,779
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
8.08%
|
8.28%
|
7.44%
|
10.75%
|
12.37%
|
11.82%
|
11.65%
|
7.34%
|
9.45%
|
13.38%
|
10.68%
|
11.96%
|
12.81%
|
7.6%
|
14.86%
|
11.25%
|
12.98%
|
13.05%
|
6.86%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
32.04
|
-
|
27.08
|
-
|
26.41
|
47.15
|
27.08
|
17.90
|
-
|
30.66
|
27.16
|
57.82
|
37.02
|
-
|
39.85
|
32.89
|
72.74
|
41.92
|
20.95
|
-
|
38.13
|
34.63
|
-
|
50.85
|
31.43
|
-
|
Dividend per Share
|
6.500
|
-
|
6.500
|
-
|
-
|
7.500
|
-
|
-
|
-
|
-
|
-
|
10.00
|
-
|
-
|
-
|
12.00
|
12.00
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/13/19
|
5/12/20
|
11/12/20
|
5/12/21
|
11/11/21
|
11/11/21
|
2/10/22
|
5/12/22
|
5/12/22
|
8/9/22
|
11/10/22
|
11/10/22
|
2/13/23
|
5/12/23
|
8/9/23
|
11/10/23
|
11/10/23
|
2/9/24
|
5/13/24
|
5/13/24
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
32,687
|
38,012
|
44,865
|
51,408
|
68,258
|
74,070
|
82,933
|
112,345
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
15,128
|
11,971
|
9,574
|
10,844
|
17,748
|
24,145
|
29,017
|
33,546
|
ROE (net income / shareholders' equity)
|
7.6%
|
11.4%
|
11.7%
|
12.6%
|
13.6%
|
13.6%
|
13.8%
|
14.2%
|
ROA (Net income/ Total Assets)
|
9.44%
|
10.9%
|
10.8%
|
11.6%
|
12.2%
|
12.9%
|
9.6%
|
10.4%
|
Assets
1 |
103,773
|
141,070
|
154,437
|
180,817
|
216,658
|
239,071
|
356,324
|
371,959
|
Book Value Per Share
2 |
574.0
|
609.0
|
682.0
|
780.0
|
917.0
|
1,078
|
1,112
|
1,263
|
Cash Flow per Share
|
70.00
|
94.10
|
101.0
|
124.0
|
148.0
|
172.0
|
-
|
-
|
Capex
1 |
6,617
|
7,069
|
10,434
|
11,948
|
12,024
|
10,100
|
9,067
|
9,300
|
Capex / Sales
|
3.6%
|
3.75%
|
5.76%
|
5.98%
|
5.04%
|
3.73%
|
3.04%
|
2.91%
|
Announcement Date
|
5/10/19
|
5/12/20
|
5/12/21
|
5/12/22
|
5/12/23
|
5/13/24
|
-
|
-
|
Last Close Price
2,882
JPY Average target price
3,955
JPY Spread / Average Target +37.25% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.34% | 4.21B | | +34.35% | 705B | | +30.88% | 583B | | -3.49% | 364B | | +20.15% | 332B | | +6.19% | 291B | | +14.94% | 238B | | -3.07% | 210B | | +10.38% | 209B | | +9.21% | 169B |
Other Pharmaceuticals
|